Federal Register / Vol. 60, No. 97 / Friday, May 19, 1995 / Proposed Rules 26853

amendment will be granted or denied by

the Director of Personnel or, for records

maintained by the Inspector General,

the Inspector General. If the request is

granted, the Director of Personnel, or,

the Inspector General, for records

maintained by the Inspector General,

shall promptly make any correction of

any portion of the record which the

individual believes is not accurate,

relevant, timely, or complete. If,

however, the request is denied, the

Director of Personnel shall inform the

individual of the refusal to amend the

record in accordance with the

individual’s request and give the

reason(s) for the refusal. In cases where

the Director of Personnel or the

Inspector General has refused to amend

in accordance with an individual’s

request, he or she also shall advise the

individual of the procedures under

§ 201.29 of these regulations for the

individual to request a review of that

refusal by the full Commission or by an

officer designated by the Commission.

5. Paragraphs (a) through (d) of

§ 201.29 are revised to read as follows:

§ 201.29 Commission review of request for

correction or amendment to record.

(a) The individual who disagrees with

the refusal of the Director of Personnel

or the Inspector General to amend the

record may request a review of the

refusal by the Commission. All requests

for review of refusals to amend records

should be addressed to the Chairman,

United States International Trade

Commission, 500 E Street, SW.,

Washington, DC 20436, and shall clearly

indicate both on the envelope and in the

letter that it is a Privacy Act review

request.

(b) Not later than 30 days (Saturdays,

Sundays, and Federal legal public

holidays excluded) from the date on

which the Commission receives a

request for review of the Director of

Personnel’s or the Inspector General’s

refusal to amend the record, the

Commission shall complete such a

review and make a final determination

thereof unless, for good cause shown,

the Commission extends the 30-day

period.

(c) After the individual’s request to

amend his or her records has been

reviewed by the Commission, if the

Commission agrees with the Director of

Personnel’s or the Inspector General’s

refusal to amend the record in

accordance with the individual’s

request, the Commission shall: (1)

Notify the individual in writing of the

Commission’s decision; (2) advise the

individual that he or she has the right

to file a concise statement of

disagreement with the Commission

which sets forth his or her reasons for

disagreement with the refusal of the

Commission to amend the records; and

(3) notify the individual of his or her

legal right to judicial review of the

Commission’s final determination.

(d) In any disclosure, containing

information about which the individual

has filed a statement of disagreement,

the Director of Personnel, or, for records

maintained by the Inspector General,

the Inspector General, shall clearly note

any portion of the record which is

disputed and shall provide copies of the

statement and, if the Commission deems

it appropriate, copies of a concise

statement of the reasons of the

Commission for not making the

amendments requested, to persons or

other agencies to whom the disputed

record has been disclosed.

6. Paragraph (b) of § 201.30 is revised

to read as follows:

§ 201.30 Commission disclosure of record

to person other than the individual to whom

it pertains.

(b) Except for disclosures either to

officers and employees of the

Commission, or, to contractor

employees who, in the Inspector

General’s or the Director of Personnel’s

judgment, are acting as federal

employees, who have a need for the

record in the performance of their

duties, and any disclosure required by

5 U.S.C. § 552, the Director of Personnel

shall keep an accurate accounting of: (1)

The date, nature, and purpose of each

disclosure of a record to any person or

to another agency under paragraph (a) of

this section; and (2) the name or address

of the person or agency to whom the

disclosure is made.

Issued: May 15, 1995.

By order of the Commission.

Donna R. Koehnke,

Secretary.

[FR Doc. 95–12360 Filed 5–18–95; 8:45 am]

BILLING CODE 7020–02–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

21 CFR Part 146

[Docket No. 94N–0452]

RIN 0905–AC48

Canned Fruit Nectars; Proposal to

Revoke the Stayed Standard of

Identity; Correction

AGENCY: Food and Drug Administration,

HHS.

ACTION: Proposed rule, correction.

SUMMARY: The Food and Drug

Administration (FDA) is correcting a

proposed rule that appeared in the

Federal Register of April 21, 1995 (60

FR 19866). The document proposed to

revoke the standard of identity for

canned fruit nectars. The document was

published with an inadvertent error in

the preamble section. This document

corrects that error.

FOR FURTHER INFORMATION CONTACT:

Nannie H. Rainey, Center for Food

Safety and Applied Nutrition (HFS–

158), Food and Drug Administration,

200 C St. SW., Washington, DC 20204,

202–205–5099.

In FR Doc. 95–9949, appearing on

page 19866 in the Federal Register of

Friday, April 21, 1995, the following

correction is made:

1. On page 19867, in the third

column, under ‘‘IV. Request for

Comments’’, line 2, ‘‘June 20’’ is

corrected to read ‘‘July 5’’.

Dated: May 10, 1995.

William B. Schultz,

Deputy Commissioner for Policy.

[FR Doc. 95–12294 Filed 5–18–95; 8:45 am]

BILLING CODE 4160–01–F

21 CFR Part 201

[Docket No. 92N–0311]

Topical Drug Products Containing

Benzoyl Peroxide; Required Labeling;

Extension of Comment Period

AGENCY: Food and Drug Administration,

HHS.

ACTION: Proposed rule; extension of

comment period.

SUMMARY: The Food and Drug

Administration (FDA) is extending to

July 17, 1995, the comment period for

the proposed rule to include additional

labeling (warning and directions) for all

topically-applied acne treatment drug

products containing benzoyl peroxide,

which appeared in the Federal Register

of February 17, 1995 (60 FR 9554). FDA

is taking this action in response to a

request to extend the comment period.

DATES: Written comments by July 17,

1995.

ADDRESSES: Submit written comments

to the Dockets Management Branch

(HFA–305), Food and Drug

Administration, rm. 1–23, 12420

Parklawn Dr., Rockville, MD 20857.

FOR FURTHER INFORMATION CONTACT:

William E. Gilbertson, Center for Drug

Evaluation and Research (HFD–810),

Food and Drug Administration, 5600

Fishers Lane, Rockville, MD 20857,

301–594–5000.